GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » Price-to-Owner-Earnings

Syncom Formulation (India) (NSE:SYNCOMF) Price-to-Owner-Earnings : 93.21 (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) Price-to-Owner-Earnings?

As of today (2024-05-11), Syncom Formulation (India)'s share price is ₹13.05. Syncom Formulation (India)'s Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹0.14. It's Price-to-Owner-Earnings for today is 93.21.


The historical rank and industry rank for Syncom Formulation (India)'s Price-to-Owner-Earnings or its related term are showing as below:

NSE:SYNCOMF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.35   Med: 16.21   Max: 511.67
Current: 102.57

During the past 13 years, the highest Price-to-Owner-Earnings of Syncom Formulation (India) was 511.67. The lowest was 7.35. And the median was 16.21.


NSE:SYNCOMF's Price-to-Owner-Earnings is ranked worse than
88.07% of 419 companies
in the Drug Manufacturers industry
Industry Median: 27.85 vs NSE:SYNCOMF: 102.57

As of today (2024-05-11), Syncom Formulation (India)'s share price is ₹13.05. Syncom Formulation (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.34. Therefore, Syncom Formulation (India)'s PE Ratio for today is 38.38.

As of today (2024-05-11), Syncom Formulation (India)'s share price is ₹13.05. Syncom Formulation (India)'s EPS without NRI for the trailing twelve months (TTM) ended in was ₹0.34. Therefore, Syncom Formulation (India)'s PE Ratio without NRI for today is 38.50.

During the past 13 years, Syncom Formulation (India)'s highest PE Ratio without NRI was 90.30. The lowest was 3.52. And the median was 24.61.


Syncom Formulation (India) Price-to-Owner-Earnings Historical Data

The historical data trend for Syncom Formulation (India)'s Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Price-to-Owner-Earnings Chart

Syncom Formulation (India) Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 42.14

Syncom Formulation (India) Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 42.14 - - -

Competitive Comparison of Syncom Formulation (India)'s Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Price-to-Owner-Earnings falls into.



Syncom Formulation (India) Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Syncom Formulation (India)'s Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=13.05/0.14
=93.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India)  (NSE:SYNCOMF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Syncom Formulation (India) Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines